+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Coronary Stents Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
Coronary Stents Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030- Product Image
New

Coronary Stents Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • PDF Icon

    Report

  • 199 Pages
  • May 2025
  • Region: Global, United States
  • 360iResearch™
  • ID: 6084219
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Coronary Stents Market grew from USD 9.31 billion in 2024 to USD 10.30 billion in 2025. It is expected to continue growing at a CAGR of 10.51%, reaching USD 16.97 billion by 2030.

The global coronary stents market has emerged as a cornerstone in interventional cardiology, playing a pivotal role in the treatment of arterial blockages and the prevention of recurrent cardiac events. Fueled by rising prevalence of coronary artery disease, aging populations, and heightened patient awareness, demand for advanced stent technologies continues to accelerate. Over recent years, the introduction of drug-eluting stents and the evolution of bioresorbable scaffolds have redefined clinical outcomes by reducing restenosis rates and enhancing vessel healing. Innovations in materials and design have further improved deliverability and radial strength while minimizing inflammatory responses. As healthcare systems worldwide strive to optimize cost efficiencies and patient quality of life, market participants are intensifying efforts in research, strategic collaborations, and manufacturing capabilities to secure competitive advantage. This introduction sets the stage for an in-depth exploration of key trends, regulatory impacts, segmentation dynamics, regional performance, major players, and actionable strategies shaping the coronary stents landscape today.

Transformative Shifts in the Landscape

Over the past decade, the coronary stents arena has undergone a remarkable metamorphosis marked by leaps in device sophistication and therapeutic precision. The transition from bare metal frameworks to polymer-based drug-eluting technologies has significantly reduced neointimal proliferation, thereby extending time to reintervention. Concurrently, bioresorbable vascular scaffolds have emerged on the clinical horizon, promising temporary support with eventual absorption to restore native vessel physiology. More recently, dual therapy constructs that combine antiproliferative coatings with anticoagulants or immunomodulators have begun to address complex lesion subsets and high-risk patient cohorts. Beyond material and pharmacologic refinements, advances in strut architecture-ranging from ultra-thin tapered designs to supersized configurations-have optimized radial strength, flexibility, and deliverability in tortuous anatomies. On the regulatory front, accelerated pathways for breakthrough devices have shortened time-to-market, while post-market surveillance requirements have spurred comprehensive clinical registries. Meanwhile, integration of digital tools including intravascular imaging, robotics, and AI-guided lesion assessment is shaping next-generation procedural workflows. Taken together, these transformative shifts underscore a dynamic environment in which safety, efficacy, and cost-effectiveness converge to redefine standards of care.

Cumulative Impact of United States Tariffs in 2025

The imposition of targeted U.S. tariffs in 2025 has introduced multifaceted challenges across the coronary stents value chain. Raw materials such as cobalt-chromium alloys and biodegradable polymers have become subject to increased import duties, driving unit production costs upward. Simultaneously, the levying of tariffs on specialized manufacturing equipment has compelled certain producers to reassess offshore fabrication strategies in favor of domestic expansion. This reconfiguration has elevated capital expenditure burdens, yet it may yield long-term advantages through enhanced supply chain resilience. Furthermore, end users in ambulatory surgical centers and government hospitals are experiencing pricing pressures that could influence procurement cycles and contractual negotiations. In response, leading firms have accelerated efforts to localize assembly operations, renegotiate supplier agreements, and optimize logistics pathways. Additionally, some stakeholders are leveraging transparent cost-pass-through models to maintain margin integrity while preserving access for patients. As the tariff landscape continues to evolve, sustained collaboration with regulatory authorities and proactive risk management will be critical for stabilizing costs and ensuring uninterrupted device availability.

Key Segmentation Insights

Examining the market through multiple dimensions reveals critical insights into product preferences, material selections, end-user channels, clinical applications, and design innovations. In terms of product type, the adoption of drug-eluting stents, particularly polymer-based variants, remains dominant due to their proven reduction in restenosis. However, second-generation bare metal stents continue to hold relevance in settings where cost constraints are paramount, while naturally derived bioresorbable scaffolds are gaining traction in niche low-risk cohorts. Composite materials, blending ceramic-polymer composites with metal-polymer hybrids, are emerging as a compelling alternative to traditional stainless steel and cobalt-chromium platforms, offering a balance of strength and biocompatibility. Polymeric stents, especially those utilizing biodegradable matrices, are drawing interest for temporary scaffolding in vessels with anticipated healing profiles. On the end-user front, hospitals-both private and government-owned-drive volume owing to their capacity to manage complex angioplasty procedures, whereas multi-specialty ambulatory centers are capitalizing on streamlined elective interventions. Applications extend beyond conventional angioplasty to encompass treatment algorithms for acute coronary syndrome and varied angina presentations. Meanwhile, design innovation around closed-cell architectures with tapered struts and open-cell configurations with ultra-thin profiles is enabling robust radial support without compromising flexibility. Collectively, these segmentation insights illuminate the interplay between clinical demands and technological advancements that will inform product development and commercialization strategies.

Key Regional Insights

Regional dynamics exhibit pronounced variation driven by healthcare infrastructure, reimbursement frameworks, and patient demographics. In the Americas, a mature cardiovascular market underpinned by well-established interventional cardiology networks continues to prioritize premium drug-eluting platforms, while strategic partnerships are forging pathways for localized manufacturing. Europe, the Middle East & Africa presents a heterogeneous environment: Western Europe maintains high adoption rates of next-generation stents under universal healthcare schemes, whereas emerging markets in the Middle East and Africa are gradually integrating advanced devices as access expands. Pricing sensitivity in some EMEA regions has bolstered demand for cost-effective bare metal systems and second-generation constructs. Asia-Pacific stands out for rapid uptake of bioresorbable and polymer-free drug-eluting solutions, supported by domestic champions investing heavily in R&D. China, India, and Japan are driving volume with expanding hospital networks and rising cardiovascular disease prevalence, even as regulatory harmonization efforts streamline approvals and post-market surveillance. Together, these regional insights guide market entry tactics, resource allocation, and pricing models tailored to local clinical and economic considerations.

Key Companies Insights

The competitive landscape is defined by a cadre of multinational medtech leaders and ambitious regional innovators. Abbott Laboratories continues to spearhead polymer-based drug-eluting technologies, while Boston Scientific Corporation and Medtronic PLC are intensifying investments in ultra-thin strut and dual therapy platforms. Johnson & Johnson Services, Inc. leverages its global reach to promote next-generation drug-eluting scaffolds, and B Braun Melsungen AG, alongside Becton, Dickinson and Company, is deepening its portfolio through strategic acquisitions. Biotronik SE & Co. KG and Biosensors International Group, Ltd. are carving niches in bioresorbable scaffolding, whereas Elixir Medical Corporation focuses on polymer-free drug delivery. Cook Medical Incorporated and REVA Medical, Inc. pursue novel scaffold geometries, and Translumina GmbH investigates AI-driven deployment systems. On the regional front, Lepu Medical Technology, Meril Life Sciences Private Limited, MicroPort Scientific Corporation, and Shandong JW Medical Systems LTD. are capitalizing on domestic manufacturing strengths to enhance cost competitiveness. Integer Holdings Corporation, Siemens Healthineers AG, Stentys SA, Terumo Corporation, and Vascular Concepts Limited further augment the ecosystem, each bringing unique material or design expertise. Together, these companies underscore a market driven by relentless innovation, strategic partnerships, and localized execution.

Actionable Recommendations for Industry Leaders

Industry leaders must embrace a multilateral approach to sustain growth and fortify market positioning. First, advancing R&D pipelines through cross-functional collaborations can accelerate breakthroughs in dual therapy and bioresorbable scaffolds while reducing time to clinical validation. Second, diversifying manufacturing footprints via targeted nearshoring will mitigate tariff exposure and bolster supply chain agility. Third, strengthening engagement with payers and healthcare providers through value-based contracting can align pricing models with long-term patient outcomes, enhancing reimbursement access. Fourth, integrating digital solutions-such as intravascular imaging analytics and AI-driven deployment guidance-will differentiate procedural workflows and improve clinical adoption. Fifth, deploying region-specific go-to-market tactics that account for local regulatory ecosystems and reimbursement nuances will ensure efficient resource allocation and maximize penetration. By pursuing these strategic imperatives in parallel, stakeholders can navigate evolving external pressures, respond to shifting clinical demands, and capture emergent opportunities in the coronary stents ecosystem.

Conclusion

In summary, the coronary stents market stands at a crossroads of clinical innovation, regulatory recalibration, and geopolitical influences. The ongoing evolution of device technologies-from polymer-based drug elution to bioresorbable scaffolds and dual therapy constructs-continues to elevate standards of care and expand therapeutic options. Concurrently, external factors such as U.S. tariff adjustments in 2025 have reshaped cost structures and supply chain architectures, prompting a recalibration of manufacturing and procurement strategies. Deep segmentation analyses reveal nuanced preferences across product types, materials, end users, and applications, while regional insights highlight divergent adoption patterns across the Americas, EMEA, and Asia-Pacific. The competitive arena is marked by robust efforts from both global medtech titans and agile regional innovators, each vying to define the next frontier in interventional cardiology. By embracing research collaborations, optimizing operational footprints, and refining value propositions, market participants are well positioned to navigate challenges and harness growth avenues in this dynamic landscape.

Market Segmentation & Coverage

This research report categorizes the Coronary Stents Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Bare Metal Stents
    • First Generation
    • Second Generation
  • Bioresorbable Vascular Scaffolds
    • Naturally Derived
    • Synthetic
  • Coated Stents
    • Antibacterial Coated
    • Antiproliferative Coated
    • Heparin Coated
  • Drug-Eluting Stents
    • Polymer-Based
    • Polymer-Free
  • Dual Therapy Stents
    • DES Coating With Anticoagulants
    • DES Coating With Immunomodulators
  • Composite Materials
    • Ceramic-Polymer Composite
    • Metal-Polymer Hybrid
  • Metallic Stents
    • Cobalt Chromium
    • Platinum Chromium
    • Stainless Steel
  • Polymeric Stents
    • Biodegradable Polymers
    • High-Strength Polymers
  • Ambulatory Surgical Centers
    • Multi-Specialty Centers
    • Single-Specialty Centers
  • Hospitals
    • Government Hospitals
    • Private Hospitals
  • Angioplasty
    • Elective Angioplasty
    • Primary Angioplasty
  • Coronary Artery Disease
    • Acute Coronary Syndrome
    • Stable Angina
    • Unstable Angina
  • Closed-Cell Design
    • Low Metal Burden
    • Tapered Strut Technology
  • Open-Cell Design
    • Supersized Strut
    • Ultra-Thin Strut

This research report categorizes the Coronary Stents Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Coronary Stents Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Abbott Laboratories
  • B Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biosensors International Group, Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical Incorporated
  • Elixir Medical Corporation
  • Integer Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology
  • Medtronic PLC
  • Meril Life Sciences Private Limited
  • MicroPort Scientific Corporation
  • REVA Medical, Inc.
  • Shandong JW Medical Systems LTD.
  • Siemens Healthineers AG
  • Stentys SA
  • Terumo Corporation
  • Translumina GmbH
  • Vascular Concepts Limited

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Coronary Stents Market, by Product Type
8.1. Introduction
8.2. Bare Metal Stents
8.2.1. First Generation
8.2.2. Second Generation
8.3. Bioresorbable Vascular Scaffolds
8.3.1. Naturally Derived
8.3.2. Synthetic
8.4. Coated Stents
8.4.1. Antibacterial Coated
8.4.2. Antiproliferative Coated
8.4.3. Heparin Coated
8.5. Drug-Eluting Stents
8.5.1. Polymer-Based
8.5.2. Polymer-Free
8.6. Dual Therapy Stents
8.6.1. DES Coating With Anticoagulants
8.6.2. DES Coating With Immunomodulators
9. Coronary Stents Market, by Material Type
9.1. Introduction
9.2. Composite Materials
9.2.1. Ceramic-Polymer Composite
9.2.2. Metal-Polymer Hybrid
9.3. Metallic Stents
9.3.1. Cobalt Chromium
9.3.2. Platinum Chromium
9.3.3. Stainless Steel
9.4. Polymeric Stents
9.4.1. Biodegradable Polymers
9.4.2. High-Strength Polymers
10. Coronary Stents Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.2.1. Multi-Specialty Centers
10.2.2. Single-Specialty Centers
10.3. Hospitals
10.3.1. Government Hospitals
10.3.2. Private Hospitals
11. Coronary Stents Market, by Application
11.1. Introduction
11.2. Angioplasty
11.2.1. Elective Angioplasty
11.2.2. Primary Angioplasty
11.3. Coronary Artery Disease
11.3.1. Acute Coronary Syndrome
11.3.2. Stable Angina
11.3.3. Unstable Angina
12. Coronary Stents Market, by Design Innovation
12.1. Introduction
12.2. Closed-Cell Design
12.2.1. Low Metal Burden
12.2.2. Tapered Strut Technology
12.3. Open-Cell Design
12.3.1. Supersized Strut
12.3.2. Ultra-Thin Strut
13. Americas Coronary Stents Market
13.1. Introduction
13.2. Argentina
13.3. Brazil
13.4. Canada
13.5. Mexico
13.6. United States
14. Asia-Pacific Coronary Stents Market
14.1. Introduction
14.2. Australia
14.3. China
14.4. India
14.5. Indonesia
14.6. Japan
14.7. Malaysia
14.8. Philippines
14.9. Singapore
14.10. South Korea
14.11. Taiwan
14.12. Thailand
14.13. Vietnam
15. Europe, Middle East & Africa Coronary Stents Market
15.1. Introduction
15.2. Denmark
15.3. Egypt
15.4. Finland
15.5. France
15.6. Germany
15.7. Israel
15.8. Italy
15.9. Netherlands
15.10. Nigeria
15.11. Norway
15.12. Poland
15.13. Qatar
15.14. Russia
15.15. Saudi Arabia
15.16. South Africa
15.17. Spain
15.18. Sweden
15.19. Switzerland
15.20. Turkey
15.21. United Arab Emirates
15.22. United Kingdom
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. B Braun Melsungen AG
16.3.3. Becton, Dickinson and Company
16.3.4. Biosensors International Group, Ltd.
16.3.5. Biotronik SE & Co. KG
16.3.6. Boston Scientific Corporation
16.3.7. Cook Medical Incorporated
16.3.8. Elixir Medical Corporation
16.3.9. Integer Holdings Corporation
16.3.10. Johnson & Johnson Services, Inc.
16.3.11. Lepu Medical Technology
16.3.12. Medtronic PLC
16.3.13. Meril Life Sciences Private Limited
16.3.14. MicroPort Scientific Corporation
16.3.15. REVA Medical, Inc.
16.3.16. Shandong JW Medical Systems LTD.
16.3.17. Siemens Healthineers AG
16.3.18. Stentys SA
16.3.19. Terumo Corporation
16.3.20. Translumina GmbH
16.3.21. Vascular Concepts Limited
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CORONARY STENTS MARKET MULTI-CURRENCY
FIGURE 2. CORONARY STENTS MARKET MULTI-LANGUAGE
FIGURE 3. CORONARY STENTS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CORONARY STENTS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CORONARY STENTS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CORONARY STENTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CORONARY STENTS MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CORONARY STENTS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CORONARY STENTS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CORONARY STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CORONARY STENTS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CORONARY STENTS MARKET SIZE, BY DESIGN INNOVATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CORONARY STENTS MARKET SIZE, BY DESIGN INNOVATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES CORONARY STENTS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES CORONARY STENTS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CORONARY STENTS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. CORONARY STENTS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. CORONARY STENTS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CORONARY STENTS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CORONARY STENTS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CORONARY STENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CORONARY STENTS MARKET SIZE, BY FIRST GENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CORONARY STENTS MARKET SIZE, BY SECOND GENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CORONARY STENTS MARKET SIZE, BY NATURALLY DERIVED, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CORONARY STENTS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CORONARY STENTS MARKET SIZE, BY COATED STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CORONARY STENTS MARKET SIZE, BY ANTIBACTERIAL COATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CORONARY STENTS MARKET SIZE, BY ANTIPROLIFERATIVE COATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CORONARY STENTS MARKET SIZE, BY HEPARIN COATED, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CORONARY STENTS MARKET SIZE, BY COATED STENTS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CORONARY STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMER-FREE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CORONARY STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CORONARY STENTS MARKET SIZE, BY DUAL THERAPY STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CORONARY STENTS MARKET SIZE, BY DES COATING WITH ANTICOAGULANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CORONARY STENTS MARKET SIZE, BY DES COATING WITH IMMUNOMODULATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CORONARY STENTS MARKET SIZE, BY DUAL THERAPY STENTS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CORONARY STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CORONARY STENTS MARKET SIZE, BY COMPOSITE MATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CORONARY STENTS MARKET SIZE, BY CERAMIC-POLYMER COMPOSITE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CORONARY STENTS MARKET SIZE, BY METAL-POLYMER HYBRID, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CORONARY STENTS MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CORONARY STENTS MARKET SIZE, BY METALLIC STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CORONARY STENTS MARKET SIZE, BY COBALT CHROMIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CORONARY STENTS MARKET SIZE, BY PLATINUM CHROMIUM, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CORONARY STENTS MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CORONARY STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMERIC STENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CORONARY STENTS MARKET SIZE, BY BIODEGRADABLE POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CORONARY STENTS MARKET SIZE, BY HIGH-STRENGTH POLYMERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CORONARY STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CORONARY STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CORONARY STENTS MARKET SIZE, BY MULTI-SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CORONARY STENTS MARKET SIZE, BY SINGLE-SPECIALTY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL CORONARY STENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL CORONARY STENTS MARKET SIZE, BY GOVERNMENT HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL CORONARY STENTS MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL CORONARY STENTS MARKET SIZE, BY ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL CORONARY STENTS MARKET SIZE, BY ELECTIVE ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL CORONARY STENTS MARKET SIZE, BY PRIMARY ANGIOPLASTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL CORONARY STENTS MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL CORONARY STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL CORONARY STENTS MARKET SIZE, BY ACUTE CORONARY SYNDROME, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL CORONARY STENTS MARKET SIZE, BY STABLE ANGINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL CORONARY STENTS MARKET SIZE, BY UNSTABLE ANGINA, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL CORONARY STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL CORONARY STENTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL CORONARY STENTS MARKET SIZE, BY CLOSED-CELL DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL CORONARY STENTS MARKET SIZE, BY LOW METAL BURDEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL CORONARY STENTS MARKET SIZE, BY TAPERED STRUT TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL CORONARY STENTS MARKET SIZE, BY CLOSED-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL CORONARY STENTS MARKET SIZE, BY OPEN-CELL DESIGN, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL CORONARY STENTS MARKET SIZE, BY SUPERSIZED STRUT, BY REGION, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL CORONARY STENTS MARKET SIZE, BY ULTRA-THIN STRUT, BY REGION, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL CORONARY STENTS MARKET SIZE, BY OPEN-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 70. AMERICAS CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. AMERICAS CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, 2018-2030 (USD MILLION)
TABLE 72. AMERICAS CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 73. AMERICAS CORONARY STENTS MARKET SIZE, BY COATED STENTS, 2018-2030 (USD MILLION)
TABLE 74. AMERICAS CORONARY STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 75. AMERICAS CORONARY STENTS MARKET SIZE, BY DUAL THERAPY STENTS, 2018-2030 (USD MILLION)
TABLE 76. AMERICAS CORONARY STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 77. AMERICAS CORONARY STENTS MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 78. AMERICAS CORONARY STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 79. AMERICAS CORONARY STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 80. AMERICAS CORONARY STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. AMERICAS CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 82. AMERICAS CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 83. AMERICAS CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. AMERICAS CORONARY STENTS MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS CORONARY STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS CORONARY STENTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS CORONARY STENTS MARKET SIZE, BY CLOSED-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS CORONARY STENTS MARKET SIZE, BY OPEN-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA CORONARY STENTS MARKET SIZE, BY COATED STENTS, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA CORONARY STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA CORONARY STENTS MARKET SIZE, BY DUAL THERAPY STENTS, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA CORONARY STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA CORONARY STENTS MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA CORONARY STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA CORONARY STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA CORONARY STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA CORONARY STENTS MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA CORONARY STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA CORONARY STENTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA CORONARY STENTS MARKET SIZE, BY CLOSED-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA CORONARY STENTS MARKET SIZE, BY OPEN-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 109. BRAZIL CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 110. BRAZIL CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, 2018-2030 (USD MILLION)
TABLE 111. BRAZIL CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 112. BRAZIL CORONARY STENTS MARKET SIZE, BY COATED STENTS, 2018-2030 (USD MILLION)
TABLE 113. BRAZIL CORONARY STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 114. BRAZIL CORONARY STENTS MARKET SIZE, BY DUAL THERAPY STENTS, 2018-2030 (USD MILLION)
TABLE 115. BRAZIL CORONARY STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 116. BRAZIL CORONARY STENTS MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 117. BRAZIL CORONARY STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 118. BRAZIL CORONARY STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 119. BRAZIL CORONARY STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. BRAZIL CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 121. BRAZIL CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 122. BRAZIL CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. BRAZIL CORONARY STENTS MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 124. BRAZIL CORONARY STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 125. BRAZIL CORONARY STENTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 126. BRAZIL CORONARY STENTS MARKET SIZE, BY CLOSED-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 127. BRAZIL CORONARY STENTS MARKET SIZE, BY OPEN-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 128. CANADA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 129. CANADA CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, 2018-2030 (USD MILLION)
TABLE 130. CANADA CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 131. CANADA CORONARY STENTS MARKET SIZE, BY COATED STENTS, 2018-2030 (USD MILLION)
TABLE 132. CANADA CORONARY STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 133. CANADA CORONARY STENTS MARKET SIZE, BY DUAL THERAPY STENTS, 2018-2030 (USD MILLION)
TABLE 134. CANADA CORONARY STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 135. CANADA CORONARY STENTS MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 136. CANADA CORONARY STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 137. CANADA CORONARY STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 138. CANADA CORONARY STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. CANADA CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 140. CANADA CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 141. CANADA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. CANADA CORONARY STENTS MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 143. CANADA CORONARY STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 144. CANADA CORONARY STENTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 145. CANADA CORONARY STENTS MARKET SIZE, BY CLOSED-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 146. CANADA CORONARY STENTS MARKET SIZE, BY OPEN-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 147. MEXICO CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 148. MEXICO CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, 2018-2030 (USD MILLION)
TABLE 149. MEXICO CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 150. MEXICO CORONARY STENTS MARKET SIZE, BY COATED STENTS, 2018-2030 (USD MILLION)
TABLE 151. MEXICO CORONARY STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 152. MEXICO CORONARY STENTS MARKET SIZE, BY DUAL THERAPY STENTS, 2018-2030 (USD MILLION)
TABLE 153. MEXICO CORONARY STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 154. MEXICO CORONARY STENTS MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 155. MEXICO CORONARY STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 156. MEXICO CORONARY STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 157. MEXICO CORONARY STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 158. MEXICO CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 159. MEXICO CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 160. MEXICO CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. MEXICO CORONARY STENTS MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 162. MEXICO CORONARY STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 163. MEXICO CORONARY STENTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 164. MEXICO CORONARY STENTS MARKET SIZE, BY CLOSED-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 165. MEXICO CORONARY STENTS MARKET SIZE, BY OPEN-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 166. UNITED STATES CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 167. UNITED STATES CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, 2018-2030 (USD MILLION)
TABLE 168. UNITED STATES CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 169. UNITED STATES CORONARY STENTS MARKET SIZE, BY COATED STENTS, 2018-2030 (USD MILLION)
TABLE 170. UNITED STATES CORONARY STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 171. UNITED STATES CORONARY STENTS MARKET SIZE, BY DUAL THERAPY STENTS, 2018-2030 (USD MILLION)
TABLE 172. UNITED STATES CORONARY STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 173. UNITED STATES CORONARY STENTS MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 174. UNITED STATES CORONARY STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 175. UNITED STATES CORONARY STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 176. UNITED STATES CORONARY STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. UNITED STATES CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 178. UNITED STATES CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 179. UNITED STATES CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. UNITED STATES CORONARY STENTS MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 181. UNITED STATES CORONARY STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 182. UNITED STATES CORONARY STENTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 183. UNITED STATES CORONARY STENTS MARKET SIZE, BY CLOSED-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 184. UNITED STATES CORONARY STENTS MARKET SIZE, BY OPEN-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 185. UNITED STATES CORONARY STENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 186. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, 2018-2030 (USD MILLION)
TABLE 188. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 189. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY COATED STENTS, 2018-2030 (USD MILLION)
TABLE 190. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 191. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY DUAL THERAPY STENTS, 2018-2030 (USD MILLION)
TABLE 192. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 193. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 194. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 195. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 196. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 197. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 198. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 199. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 201. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY CLOSED-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY OPEN-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC CORONARY STENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 206. AUSTRALIA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. AUSTRALIA CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, 2018-2030 (USD MILLION)
TABLE 208. AUSTRALIA CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 209. AUSTRALIA CORONARY STENTS MARKET SIZE, BY COATED STENTS, 2018-2030 (USD MILLION)
TABLE 210. AUSTRALIA CORONARY STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 211. AUSTRALIA CORONARY STENTS MARKET SIZE, BY DUAL THERAPY STENTS, 2018-2030 (USD MILLION)
TABLE 212. AUSTRALIA CORONARY STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 213. AUSTRALIA CORONARY STENTS MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 214. AUSTRALIA CORONARY STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 215. AUSTRALIA CORONARY STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 216. AUSTRALIA CORONARY STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. AUSTRALIA CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 218. AUSTRALIA CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 219. AUSTRALIA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. AUSTRALIA CORONARY STENTS MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 221. AUSTRALIA CORONARY STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 222. AUSTRALIA CORONARY STENTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 223. AUSTRALIA CORONARY STENTS MARKET SIZE, BY CLOSED-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 224. AUSTRALIA CORONARY STENTS MARKET SIZE, BY OPEN-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 225. CHINA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 226. CHINA CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, 2018-2030 (USD MILLION)
TABLE 227. CHINA CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 228. CHINA CORONARY STENTS MARKET SIZE, BY COATED STENTS, 2018-2030 (USD MILLION)
TABLE 229. CHINA CORONARY STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 230. CHINA CORONARY STENTS MARKET SIZE, BY DUAL THERAPY STENTS, 2018-2030 (USD MILLION)
TABLE 231. CHINA CORONARY STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 232. CHINA CORONARY STENTS MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 233. CHINA CORONARY STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 234. CHINA CORONARY STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 235. CHINA CORONARY STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 236. CHINA CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 237. CHINA CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 238. CHINA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. CHINA CORONARY STENTS MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 240. CHINA CORONARY STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 241. CHINA CORONARY STENTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 242. CHINA CORONARY STENTS MARKET SIZE, BY CLOSED-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 243. CHINA CORONARY STENTS MARKET SIZE, BY OPEN-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 244. INDIA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 245. INDIA CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, 2018-2030 (USD MILLION)
TABLE 246. INDIA CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 247. INDIA CORONARY STENTS MARKET SIZE, BY COATED STENTS, 2018-2030 (USD MILLION)
TABLE 248. INDIA CORONARY STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 249. INDIA CORONARY STENTS MARKET SIZE, BY DUAL THERAPY STENTS, 2018-2030 (USD MILLION)
TABLE 250. INDIA CORONARY STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 251. INDIA CORONARY STENTS MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 252. INDIA CORONARY STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 253. INDIA CORONARY STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 254. INDIA CORONARY STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 255. INDIA CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 256. INDIA CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 257. INDIA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 258. INDIA CORONARY STENTS MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 259. INDIA CORONARY STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 260. INDIA CORONARY STENTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 261. INDIA CORONARY STENTS MARKET SIZE, BY CLOSED-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 262. INDIA CORONARY STENTS MARKET SIZE, BY OPEN-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 263. INDONESIA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 264. INDONESIA CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, 2018-2030 (USD MILLION)
TABLE 265. INDONESIA CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 266. INDONESIA CORONARY STENTS MARKET SIZE, BY COATED STENTS, 2018-2030 (USD MILLION)
TABLE 267. INDONESIA CORONARY STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 268. INDONESIA CORONARY STENTS MARKET SIZE, BY DUAL THERAPY STENTS, 2018-2030 (USD MILLION)
TABLE 269. INDONESIA CORONARY STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 270. INDONESIA CORONARY STENTS MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 271. INDONESIA CORONARY STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 272. INDONESIA CORONARY STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 273. INDONESIA CORONARY STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 274. INDONESIA CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 275. INDONESIA CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 276. INDONESIA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 277. INDONESIA CORONARY STENTS MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 278. INDONESIA CORONARY STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 279. INDONESIA CORONARY STENTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 280. INDONESIA CORONARY STENTS MARKET SIZE, BY CLOSED-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 281. INDONESIA CORONARY STENTS MARKET SIZE, BY OPEN-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 282. JAPAN CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 283. JAPAN CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, 2018-2030 (USD MILLION)
TABLE 284. JAPAN CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 285. JAPAN CORONARY STENTS MARKET SIZE, BY COATED STENTS, 2018-2030 (USD MILLION)
TABLE 286. JAPAN CORONARY STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 287. JAPAN CORONARY STENTS MARKET SIZE, BY DUAL THERAPY STENTS, 2018-2030 (USD MILLION)
TABLE 288. JAPAN CORONARY STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 289. JAPAN CORONARY STENTS MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 290. JAPAN CORONARY STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 291. JAPAN CORONARY STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 292. JAPAN CORONARY STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 293. JAPAN CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 294. JAPAN CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 295. JAPAN CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 296. JAPAN CORONARY STENTS MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 297. JAPAN CORONARY STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 298. JAPAN CORONARY STENTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 299. JAPAN CORONARY STENTS MARKET SIZE, BY CLOSED-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 300. JAPAN CORONARY STENTS MARKET SIZE, BY OPEN-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 301. MALAYSIA CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 302. MALAYSIA CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, 2018-2030 (USD MILLION)
TABLE 303. MALAYSIA CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 304. MALAYSIA CORONARY STENTS MARKET SIZE, BY COATED STENTS, 2018-2030 (USD MILLION)
TABLE 305. MALAYSIA CORONARY STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 306. MALAYSIA CORONARY STENTS MARKET SIZE, BY DUAL THERAPY STENTS, 2018-2030 (USD MILLION)
TABLE 307. MALAYSIA CORONARY STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 308. MALAYSIA CORONARY STENTS MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 309. MALAYSIA CORONARY STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 310. MALAYSIA CORONARY STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 311. MALAYSIA CORONARY STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 312. MALAYSIA CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 313. MALAYSIA CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 314. MALAYSIA CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 315. MALAYSIA CORONARY STENTS MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 316. MALAYSIA CORONARY STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 317. MALAYSIA CORONARY STENTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 318. MALAYSIA CORONARY STENTS MARKET SIZE, BY CLOSED-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 319. MALAYSIA CORONARY STENTS MARKET SIZE, BY OPEN-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 320. PHILIPPINES CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 321. PHILIPPINES CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, 2018-2030 (USD MILLION)
TABLE 322. PHILIPPINES CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 323. PHILIPPINES CORONARY STENTS MARKET SIZE, BY COATED STENTS, 2018-2030 (USD MILLION)
TABLE 324. PHILIPPINES CORONARY STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 325. PHILIPPINES CORONARY STENTS MARKET SIZE, BY DUAL THERAPY STENTS, 2018-2030 (USD MILLION)
TABLE 326. PHILIPPINES CORONARY STENTS MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 327. PHILIPPINES CORONARY STENTS MARKET SIZE, BY COMPOSITE MATERIALS, 2018-2030 (USD MILLION)
TABLE 328. PHILIPPINES CORONARY STENTS MARKET SIZE, BY METALLIC STENTS, 2018-2030 (USD MILLION)
TABLE 329. PHILIPPINES CORONARY STENTS MARKET SIZE, BY POLYMERIC STENTS, 2018-2030 (USD MILLION)
TABLE 330. PHILIPPINES CORONARY STENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 331. PHILIPPINES CORONARY STENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2030 (USD MILLION)
TABLE 332. PHILIPPINES CORONARY STENTS MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 333. PHILIPPINES CORONARY STENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 334. PHILIPPINES CORONARY STENTS MARKET SIZE, BY ANGIOPLASTY, 2018-2030 (USD MILLION)
TABLE 335. PHILIPPINES CORONARY STENTS MARKET SIZE, BY CORONARY ARTERY DISEASE, 2018-2030 (USD MILLION)
TABLE 336. PHILIPPINES CORONARY STENTS MARKET SIZE, BY DESIGN INNOVATION, 2018-2030 (USD MILLION)
TABLE 337. PHILIPPINES CORONARY STENTS MARKET SIZE, BY CLOSED-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 338. PHILIPPINES CORONARY STENTS MARKET SIZE, BY OPEN-CELL DESIGN, 2018-2030 (USD MILLION)
TABLE 339. SINGAPORE CORONARY STENTS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 340. SINGAPORE CORONARY STENTS MARKET SIZE, BY BARE METAL STENTS, 2018-2030 (USD MILLION)
TABLE 341. SINGAPORE CORONARY STENTS MARKET SIZE, BY BIORESORBABLE VASCULAR SCAFFOLDS, 2018-2030 (USD MILLION)
TABLE 342. SINGAPORE CORONARY STENTS MARKET SIZE, BY COATED STENTS, 2018-2030 (USD MILLION)
TABLE 343. SINGAPORE CORONARY STENTS MARKET SIZE, BY DRUG-ELUTING STENTS, 2018-2030 (USD MILLION)
TABLE 344. SINGAPORE CORONARY STENTS MARKET SIZE, BY DUAL THERAPY STENTS, 2018-2030 (USD MILLION)

Companies Mentioned

  • Abbott Laboratories
  • B Braun Melsungen AG
  • Becton, Dickinson and Company
  • Biosensors International Group, Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Cook Medical Incorporated
  • Elixir Medical Corporation
  • Integer Holdings Corporation
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology
  • Medtronic PLC
  • Meril Life Sciences Private Limited
  • MicroPort Scientific Corporation
  • REVA Medical, Inc.
  • Shandong JW Medical Systems LTD.
  • Siemens Healthineers AG
  • Stentys SA
  • Terumo Corporation
  • Translumina GmbH
  • Vascular Concepts Limited

Methodology

Loading
LOADING...

Related Topics

Related Reports

Coronary Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Coronary Stents - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Coronary Stents Market Size, Share & Trends Analysis Report By Product, By End Use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Coronary Stents Market Size, Share & Trends Analysis Report By Product, By End Use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 120 Pages
  • Global
From
Bioresorbable Stents - Global Strategic Business Report - Product Image

Bioresorbable Stents - Global Strategic Business Report

  • Report
  • 125 Pages
  • Global
From
Bioabsorbable Eluting Coronary Stent System Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030 - Product Image

Bioabsorbable Eluting Coronary Stent System Market - Cumulative Impact of United States Tariffs 2025 - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global, United States Global, United States
From
Global Coronary Stents Market - Focused Insights 2024-2029 - Product Image

Global Coronary Stents Market - Focused Insights 2024-2029

  • Report
  • 144 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.